AUPH
Aurinia Pharmaceuticals Inc
NASDAQ: AUPH · HEALTHCARE · BIOTECHNOLOGY
$16.44
-0.93% today
Updated 2026-09-25
Market cap
$2.21B
P/E ratio
7.29
P/S ratio
7.09x
EPS (TTM)
$2.28
Dividend yield
—
52W range
$10 – $19
Volume
1.0M
Aurinia Pharmaceuticals Inc (AUPH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$16.44
12-Month target
$17.96
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.1B | $0.2B | $0.2B | $0.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 7.29x (capped 25x) · Margin: 100.80%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.